Blood flow study in acute or chronic central serous eye disease
Treatments studied
Part of Eyes & vision clinical trials.
This study measures blood flow in the eye in people with acute or chronic central serous chorioretinopathy (CSC). It uses eye scans and special imaging to better understand what’s happening and whether it may differ between short-term and long-term disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You can sign an informed consent form
- You can get the required eye imaging scans (fundus imaging)
- You have central serous chorioretinopathy in one eye either for under 4 months (acute) or 4 months or longer (chronic)
- If acute: your eye imaging shows fluid under the center of the vision (subfoveal SRF on OCT) and this is your 1st to 3rd CSC attack
- If chronic: your symptoms or vision change have lasted at least 4 months, and your imaging matches chronic CSC
- You do not have other past retinal eye diseases (like retinal detachment)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a gentle laser treatment called micropulse laser for people with chronic central serous chorioretinopathy. It aims to help dry up the fluid under the retina that has not responded to standard medications for at least 6 months.
This study looks at the link between gut bacteria and central serous chorioretinopathy (CSC), a condition where fluid builds up under the retina. It may help us understand why some people get CSC and find better ways to treat it.
This trial studies rare diseases affecting the retina or choroid using detailed eye scans (OCT). It may help doctors better understand how these conditions look in the eye and how imaging findings relate to vision.
This trial compares two treatments for chronic central serous chorioretinopathy (CSC), a condition that causes fluid buildup under the retina. It tests whether adding a light therapy (photodynamic therapy) to micropulse laser treatment helps improve vision more than laser alone.
This study is testing whether mindfulness-based stress reduction can help people with central serous chorioretinopathy (CSCR), a condition causing fluid buildup under the retina. If you have active CSCR that started recently, you might be eligible.
This trial tests a low-energy “subthreshold” laser to treat long-lasting fluid under the retina from central serous chorioretinopathy (CSCR). It may help dry up the fluid and improve vision, compared with a sham (placebo) treatment.
Hear when a new Central Serous Chorioretinopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.